C
비씨월드제약
200780KOSDAQ의약품 제조업41.5 / 100
Reference Date: 2026-07-24
Financial Score11.0 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Slightly up 2.1% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
BC World Pharm focuses on R&D of new and improved drugs, maintaining competitiveness in both domestic and international markets by exporting specialty pharmaceuticals produced in facilities compliant with FDA and EMA standards. The company is expanding its CMO/CDMO business and pursuing overseas licensing deals, addressing growing pharmaceutical demand driven by aging populations.
Number of Employees
288people
Average Salary
40.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 11.234.0Point
PBR
0.47Industry Average 0.815.5Point
Lower than industry avg (good)
ROE
-4.23Industry Average 4.010.0Point
Well below industry avg
Debt Ratio
20.12Industry Average 12.430.5Point
1.6x industry avg (risky)
Trend 2023~20251.0 / 10 points
Revenue Growth Rate
1.0 / 3
Avg ▲0.5% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼21.7% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -1.6% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (6%, downtrend)
Current 3,190Won52-week high 5,87052-week low 3,015
1-month return4.0Point
1m +2.08% (slight rise)
Volume trend3.0Point
Volume flat
Detailed Disclosure
0 totalPositive 0Neutral 0Negative 0